Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomed Nanotechnol ; 16(2): 179-192, 2020 Feb 01.
Article in English | MEDLINE | ID: mdl-32252879

ABSTRACT

Nanobiotechnology strategies for cancer treatments are currently being tested with increasing interest, except in elderly groups. It is well established that breast cancer incidence increases with age and that traditional therapies usually generate severe adverse effects, especially for elderly groups. To investigate if the benefits of nanotechnology could be extended to treating cancer in this group, citrate-coated maghemite nanoparticles (NpCit) were used for magnetohyperthermia (MHT) in combination with the administration of PLGA-Selol nanocapsule (NcSel), a formulation with antioxidant and antitumor activity. The combined therapies significantly inhibited breast Ehrlich tumor growth and prevented metastases to the lymph nodes, liver and lungs until 45 days after tumor induction, a better result than the group undergoing conventional drug treatment. The levels of TNF-α, associated with poor prognosis in Ehrlich tumor, were also normalized. Therefore, the results evidenced the potential use of these therapies for future clinical trials in elderly breast cancer patients.


Subject(s)
Adenocarcinoma , Aging , Animals , Cell Line, Tumor , Glycols , Humans , Mice , Nanoparticles , Polylactic Acid-Polyglycolic Acid Copolymer , Selenium Compounds
2.
Eur J Pharm Sci ; 139: 105056, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31446076

ABSTRACT

Topical application of aluminum-chloride phthalocyanine (AlClPc) is a challenge because of the drug's extremely low solubility, which prevents its absorption into deeper skin layers and causes molecule aggregation, reducing the photophysical effect. The goal of this study was to obtain a formulation applied in a certain condition that would allow homogeneous accumulation of AlClPc in cutaneous tissues, meaning a safer and non-invasive topical treatment for skin tumors based on photodynamic therapy. We first prepared and characterized AlClPc complexes with cyclodextrin to increase the photosensitizing agent solubility. The inclusion complex of AlClPc with hydroxypropyl-ß-cyclodextrin (HP-ßCD) amplified its loading dose in aqueous medium and maintained its photosensitizing properties in terms of reactive oxygen species production. Assays to determine the complex's in vitro cytotoxicity against murine melanoma skin cancer cells showed that when irradiated, the complex significantly reduced cell viability, whereas the absence of irradiation did not affect cell viability. Three physical techniques for permeation enhancement (i.e., tape-stripping abrasion, microneedle pretreatment and iontophoresis) were then evaluated. When applied in impaired skin, the complex could not increase drug penetration. The skin penetration of AlClPc, however, increased 2.3-fold following iontophoresis application in a shorter period compared to passive permeation. Therefore, these results suggest the administration of complexed AlClPc mediated by iontophoresis, followed by application of photodynamic therapy, might be an effective and non-invasive alternative for topical treatment of cutaneous tumors.


Subject(s)
2-Hydroxypropyl-beta-cyclodextrin/administration & dosage , Aluminum Chloride/administration & dosage , Indoles/administration & dosage , Melanoma, Experimental/drug therapy , Organometallic Compounds/administration & dosage , Photosensitizing Agents/administration & dosage , Skin Neoplasms/drug therapy , 2-Hydroxypropyl-beta-cyclodextrin/chemistry , Administration, Cutaneous , Aluminum Chloride/chemistry , Animals , Cell Line, Tumor , Cell Survival/drug effects , Indoles/chemistry , Iontophoresis , Mice , Organometallic Compounds/chemistry , Photochemotherapy , Photosensitizing Agents/chemistry , Reactive Oxygen Species/chemistry , Skin/metabolism , Skin Absorption , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...